Cureus | Primary Thyroid Lymphoma: An Analysis of the National Cancer Database
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Median Survival Time - an overview | ScienceDirect Topics
Overall survival for different subtypes of non-Hodgkin lymphoma | Download Scientific Diagram
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram
Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Non-Hodgkin lymphoma - The Lancet
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version - NCI
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors - ScienceDirect
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
Surgery for Primary Central Nervous System Lymphoma: Is It Time for Reevaluation?
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
Non-Hodgkin Lymphoma (NHL) | Treatment Challenges
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM
Intercontinental Asian Study Compiles the Relative Incidence of
